NTHI NeOnc Technologies Holdings, Inc.
Company Analysis
Latest News
🟢 NeOnc Technologies Holdings is trading 6.3% up in pre-market after scheduling an FDA meeting for NEO212
NeOnc Technologies Holdings is trading at $3.36, up 6.33% in pre-market, with the scheduled FDA meeting for NEO212 a plausible catalyst. - The company...
NTHI Schedules End-of-Phase 1 FDA Meeting for Cancer Drug Candidate NEO212
NeOnc Technologies Holdings, Inc. (NTHI) announced it has scheduled an End-of-Phase 1 meeting with the U.S. Food and Drug Administration (FDA) for its cancer...
🟢 NeOnc Technologies Holdings is trading 7.27% up in pre-market after Roth/MKM initiated coverage with Buy rating
NeOnc Technologies Holdings is trading at $3.54, up 7.27% in pre-market after Roth/MKM initiated coverage on September 24, 2026, with a Buy rating and a $20...
Roth/MKM Slaps a $20 Target on a $3.55 Brain-Cancer Stock — Can NeOnc's Science Close a 460% Gap?
Shares of NeOnc Technologies Holdings (NTHI) jumped 10.2% to $3.55 on September 24 after Roth/MKM initiated coverage with a Buy rating and a $20 price...
🟢 NeOnc Technologies Holdings is trading 10.25% up today after Roth/MKM initiated coverage with a Buy rating
NeOnc Technologies Holdings is trading 10.25% up now at $3.55 after Roth/MKM initiated coverage on September 24, 2026, with a Buy rating and a $20 price...
🟢 NeOnc Technologies Holdings is trading 6% up today after Roth/MKM initiated Buy coverage
NeOnc Technologies Holdings is trading at $3.41, up 5.90%, after Roth/MKM initiated coverage on September 24, 2026, with a Buy rating and a $20 price target. -...
🟢 NeOnc Technologies Holdings is trading 6% up in pre-market with broader biotech gains
NeOnc Technologies Holdings is trading $3.41, up 5.90%, with broad biotech strength likely supporting the move; no new company-specific announcement was...
🔴 NeOnc Technologies Holdings is trading 6.09% down today amid rising crude oil and Treasury yields
NeOnc Technologies Holdings is trading at $3.24, down 6.09%, amid broad-market pressure from rising crude oil and Treasury yields. - On September 23, 2026, the...
🟢 NeOnc Technologies Holdings is trading 6.67% up in pre-market amid XBI’s 2.61% pre-market gain
NeOnc Technologies Holdings is trading higher alongside biotech-sector strength, at $3.68 (+6.67%). • XBI was reported up 2.61% pre-market. • No fresh...
🟢 NeOnc Technologies Holdings is trading 7.83% up in after-hours trading as Nasdaq Composite gained 0.61%
NeOnc Technologies Holdings is trading at $3.72, up 7.83% in after-hours trading, with the move appearing broadly aligned with favorable technology-market...
🟢 NeOnc Technologies Holdings is trading 6.3% up in pre-market with no fresh company announcement explaining move
NeOnc Technologies Holdings is trading 6.3% up at $3.54 after rising from the September 21 close of $3.33. Searches found no fresh September 22 company...
🟢 NeOnc Technologies Holdings is trading 6.38% up today as Nasdaq and S&P 500 gain
NeOnc Technologies Holdings is trading 6.38% up at $3.47, moving alongside a strong September 21, 2026 risk-on session. - Nasdaq Composite is up 1.61% and S&P...
🔴 NeOnc Technologies Holdings is trading 5.3% down today as the cause remains unclear
NeOnc Technologies Holdings is trading at $3.23 (-5.28%) down now, with no clear company-specific catalyst identified for the September 18, 2026 decline. •...
🟢 NeOnc Technologies Holdings is trading 7% up in pre-market after redeeming $6 million in preferred stock
NeOnc Technologies Holdings is trading 7.04% up at $3.65 after redeeming $6 million of preferred stock with cash from its recent offering, avoiding...
NeOnc Insiders Bet $629,000 on Their Own Brain Cancer Drug — But Can a 24-Patient Trial Carry a Company to FDA Approval?
Shares of NeOnc Technologies Holdings surged 15.1% to $3.44 after the company disclosed that its two top executives spent $629,000 of their own money buying...
🟢 NeOnc Technologies Holdings is trading 11.04% up today after positive NEO100 Phase 2a results
NeOnc Technologies Holdings is trading 11.04% up at $3.44 after executives disclosed approximately $629,000 in open-market purchases following positive NEO100...
NTHI Executives Purchase $629,000 in Company Stock Following Positive Clinical Data
NeOnc Technologies (NTHI) disclosed that its top executives have made significant open-market stock purchases totaling approximately $629,000. These...
🟢 NeOnc Technologies Holdings is trading 10.03% up in pre-market after approximately $629,000 in executive open-market purchases
NeOnc Technologies Holdings is trading at $3.29, up 10.03%, following its September 16 announcement of approximately $629,000 in executive open-market...
🔴 NeOnc Technologies Holdings is trading 10.42% down today amid biotechnology-sector weakness as XBI ETF falls 2.11%
NeOnc Technologies Holdings is trading 10.42% down at $2.96 as biotechnology shares weaken. - The XBI ETF was down 2.11% on September 16, 2026. - The broader...
🔴 NeOnc Technologies Holdings is trading 5.29% down today amid XBI's 2.11% decline
NeOnc Technologies Holdings is trading 5.29% down now at $3.13 amid broader biotechnology-sector pressure, with XBI down 2.11%. - Opening weakness continued...